We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$14.4B
AUM Growth
+$510M
Cap. Flow
-$138M
Cap. Flow %
-0.95%
Top 10 Hldgs %
14.81%
Holding
2,666
New
35
Increased
376
Reduced
1,161
Closed
143

Sector Composition

Rank Sector Weight
1 Financials 14.42%
2 Technology 14.03%
3 Healthcare 11.38%
4 Industrials 9.94%
5 Consumer Discretionary 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THFF icon
2026
First Financial Corp
THFF
$975M
$289K ﹤0.01%
6,089
AKBA icon
2027
Akebia Therapeutics
AKBA
$241M
$288K ﹤0.01%
31,340
-460
-1% -$4.49K
BBSI icon
2028
Barrett Business Services
BBSI
$800M
$288K ﹤0.01%
21,100
ENVA icon
2029
Enova International
ENVA
$6.52B
$288K ﹤0.01%
19,420
MACK
2030
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$287K ﹤0.01%
11,830
+723
+7% +$18.1K
ANIP icon
2031
ANI Pharmaceuticals
ANIP
$1.72B
$286K ﹤0.01%
5,784
TPCO
2032
DELISTED
Tribune Publishing Company Common Stock
TPCO
$286K ﹤0.01%
20,544
-372
-2% -$5.1K
BNED icon
2033
Barnes & Noble Education
BNED
$424M
$285K ﹤0.01%
297
-2
-0.7% -$2.04K
IXYS
2034
DELISTED
IXYS Corp
IXYS
$285K ﹤0.01%
19,582
COWN
2035
DELISTED
Cowen Inc. Class A Common Stock
COWN
$285K ﹤0.01%
19,074
-1
-0% -$15
PRTY
2036
DELISTED
Party City Holdco Inc.
PRTY
$284K ﹤0.01%
20,229
LJPC
2037
DELISTED
La Jolla Pharmaceutical Company
LJPC
$284K ﹤0.01%
9,512
LPSN icon
2038
LivePerson
LPSN
$35.9M
$283K ﹤0.01%
2,752
+220
+9% +$23.5K
RPAI
2039
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$283K ﹤0.01%
19,630
-187
-0.9% -$2.79K
XOXO
2040
DELISTED
Xo Group Inc
XOXO
$283K ﹤0.01%
16,471
FRP
2041
DELISTED
Fairpoint Communications, Inc.
FRP
$283K ﹤0.01%
17,076
-445
-3% -$7.81K
ATEN icon
2042
A10 Networks
ATEN
$1.96B
$282K ﹤0.01%
30,870
CSV icon
2043
Carriage Services
CSV
$555M
$282K ﹤0.01%
10,399
FSB
2044
DELISTED
Franklin Financial Network, Inc.
FSB
$282K ﹤0.01%
7,288
FTD
2045
DELISTED
FTD Companies, Inc. Common Stock
FTD
$282K ﹤0.01%
13,997
KPTI icon
2046
Karyopharm Therapeutics
KPTI
$45.1M
$281K ﹤0.01%
1,461
AROW icon
2047
Arrow Financial
AROW
$723M
$280K ﹤0.01%
10,145
GWRE icon
2048
Guidewire Software
GWRE
$15.2B
$280K ﹤0.01%
4,968
LMAT icon
2049
LeMaitre Vascular
LMAT
$1.87B
$279K ﹤0.01%
11,330
SHOE
2050
Shoe Station Group
SHOE
$415M
$279K ﹤0.01%
22,724

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q1 2017 Portfolio in Review

As of Q1 2017, Metropolitan Life Insurance Company (MetLife) held 2,666 positions worth $14.4B, up 3.7% from $13.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q1 2017 filing shows 35 new, 376 increased, 1,161 reduced and 143 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 105,052 shares worth $5.72M. The largest sale was Spectra Energy Corp Wi, an estimated $14.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q1 2017 buy was Bioverativ Inc. Common Stock: 105,052 shares worth $5.72M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2017, an estimated $190M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q1 2017 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $11.8M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $14.6M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 15% of its $14.4B portfolio in Q1 2017.
  • Metropolitan Life Insurance Company (MetLife) opened 35 new positions and closed 143 in Q1 2017.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 3.7% quarter-over-quarter to $14.4B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2017, filed 15 May 2017.